Pessary solution for retained cleansings
Eurovet Animal Health has now launched a new product for cattle: Bovocycline 2000 mg pessary.
The incidence of retained cleansings (retained placenta/ retained foetal membranes) in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. Retained cleansings result in reduced cow fertility and a higher risk of culling due to poor fertility and have a significant economic impact, costing around 300 per cow. Most farmers prefer to use pessaries for vulval discharges in cattle by farmers and pessaries account for around 40 per cent of all treatments given for the condition.
Eurovet Animal Health has now launched a new product for cattle: Bovocycline 2000 mg pessary, for use after problem deliveries, retained cleansings and endometritis, available on prescription from a veterinary surgeon. Farmers are reminded that treatment may be needed after higher risk calvings such as twin births, induced births, or dead and still born calves.
Ruth Vernon is Technical Services Manager at Eurovet, Control of post partum problems in cows needs to be addressed in a broad ranging way. Treatment with an antibiotic that is active against the bacteria most commonly implicated in retained cleansings is only one element of a control strategy. Farmers should also think about the long term management policies they can take on farm, such as choosing the sire carefully, particularly for use on heifers, carefully controlling nutrition, maintaining strict hygiene standards and generally practising a high standard of stockmanship at calving.
For advice about the treatment of retained cleansings, farmers are advised to consult their veterinary surgeon.
Regulatory Information
Bovocycline Pessariescontains 2000 mg tetracycline hydrochloride Legal category POM-VPS.
Advice on the use of this or alternative medicines should be sought from the medicine prescriber
Use Animal Medicines Responsibly http://www.noah.co.uk/responsible/
Indications for use, specifying the target species
For treatment and prevention of post parturient disorders in cattle: for administration following dystocia, retained foetal membranes and endometritis caused by pathogens susceptible to tetracycline.
Contra-indications
Do not use in infections caused by pathogens resistant to tetracycline. Do not use in severe kidney and liver disorders. Do not use in case of hypersensitivity to tetracyclines or to any of the excipients.
Special precautions for use
Special precautions for use in animals
The product should be used based on susceptibility testing and take into account official, national and regional antimicrobial policies.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Direct contact with the skin or the mucous membranes of the user should be avoided. The use of gloves is recommended when administering the product to avoid sensitisation. Wash your hands after handling the product.
Adverse reactions (frequency and seriousness)
Long-term therapy requires careful monitoring to avoid super-infection (for example with yeasts).
Occurrence of renal disorders is enhanced in dehydrated animals.
Tetracycline can cause damage to the liver.
Photodermatitis often occurs in areas of sparsely pigmented skin if these are exposed to sunlight.
Allergic reactions are rare. In case of allergic or anaphylactic reactions, discontinue treatment immediately. Allergic reactions can be treated parenterally with steroids and antihistamins.
Use during pregnancy, lactation or lay
The product is not indicated for use during pregnancy but can be used during lactation.
Withdrawal periods
Cattle: Meat and offal 10 days
Milk 4 days
Eurovet Animal Health: From Vets For Vets
For further information contact Eurovet Animal Health. Eurovet Animal Health is an animal health company based in Cambridge, for further information contact Eurovet Animal Health, Compass House, Chivers Way, Histon, Cambridge, CB24 9AD Tel 01223 257933 E mail office@eurovet-ah.co.ukwww.eurovet-ah.co.uk
